Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Brizendine

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Diabetes Care|December 25, 2008
Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot studyElaine R Lipscomb, Emily A Finch, Edward Brizendine, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2006
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazoleL Joseph Wheat, Patricia Connolly, Melinda Smedema, et al.
The Journal of Infectious Diseases|June 27, 2002
Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infectionRoss R Haynes, Patricia A Connolly, Michelle M Durkin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Diabetes Care|December 25, 2008
Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot studyElaine R Lipscomb, Emily A Finch, Edward Brizendine, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2006
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazoleL Joseph Wheat, Patricia Connolly, Melinda Smedema, et al.
The Journal of Infectious Diseases|June 27, 2002
Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infectionRoss R Haynes, Patricia A Connolly, Michelle M Durkin, et al.
Pageof 2